Edwin Lisowski, Co-Founder and Chief Growth Officer of Addepto, oversees the company’s strategic growth, business development ...

AI expands our vision, helps us break through fixation, and challenges us to see potential where we might have overlooked it.

Starting substance use early—especially alcohol, nicotine, or cannabis—increases the likelihood of addiction later in life ( ...

Groundbreaking study uncovers plasma proteins influencing blood pressure and heart disease risk. Find out how this research ...

Q3 2025 Earnings Call November 5, 2025 5:00 PM ESTCompany ParticipantsAleksey Lakchakov - Senior Director of Finance & Head ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

This important and compelling study establishes a robust computational and experimental framework for the large-scale identification of metallophore biosynthetic clusters. The work advances beyond ...

Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug ...

Bentley Systems, Incorporated ( BSY) Q3 2025 Earnings Call November 5, 2025 8:15 AM EST Good morning, and thank you for joining Bentley Systems Q3 2025 results. I'm Eric Boyer, Bentley's Investor ...

Marina Wheeler KC is pulling a pained face at me across the meeting room at her barristers’ chambers. I’ve come to talk about her new book on navigating Britain’s relationship with Europe, A More ...

In conjunction Company provides guidance on Fiscal 2025 billings and corporate update Ottawa, Ontario–(Newsfile Corp. –) – DEFSEC Technologies Inc. (TSXV: DFSC) (TSXV: ...